ARPA-H: New Health Research Agency Faces Old Concerns About Disrupting Private Investment

Proposed Advanced Research Project Agency for Health also needs to distinguish itself from NCATS, which faced many of the same questions when it was created a decade ago. Disagreements also persist about whether ARPA-H should be housed in NIH or HHS.

Geoffrey Shiu Fei Ling speaks at House hearing on ARPA-H
Geoffrey Shiu Fei Ling, CEO of On Demand Pharmaceuticals and a former DARPA program manager, testifies in favor of creating ARPA-H to speed health care innovation. • Source: Screenshot

More from R&D

More from Pink Sheet